Biotech company Valo Health and AI healthcare firm nference have entered into a multi-year partnership to leverage AI and patient data in drug discovery and development.
The collaboration will integrate nference’s AI platform, which processes de-identified data from top academic medical centers, with Valo’s Opal Computational platform to enhance target discovery and precision medicine, according to a news release shared with Becker’s.
The partnership also grants Valo access to insights from physician notes, medical imaging, lab results and treatment data, which could help accelerate drug development.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
